AAAAAA

   
Results: 1-11 |
Results: 11

Authors: McLain, L Brown, JL Cheung, L Reading, SA Parry, C Jones, TD Cleveland, SM Dimmock, NJ
Citation: L. Mclain et al., Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutantof human immunodeficiency virus type 1, ARCH VIROL, 146(1), 2001, pp. 157-166

Authors: Reading, SA Edwards, MJ Dimmock, NJ
Citation: Sa. Reading et al., Increasing the efficiency of virus infectivity assays: small inoculum volumes are as effective as centrifugal enhancement, J VIROL MET, 98(2), 2001, pp. 167-169

Authors: Wilson, JN Nokes, DJ Dimmock, NJ
Citation: Jn. Wilson et al., Analysis of the relationship between immunogenicity and immunity for viralsubunit vaccines, J MED VIROL, 64(4), 2001, pp. 560-568

Authors: Edwards, MJ Dimmock, NJ
Citation: Mj. Edwards et Nj. Dimmock, Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event, J VIROLOGY, 75(21), 2001, pp. 10208-10218

Authors: Edwards, MJ Dimmock, NJ
Citation: Mj. Edwards et Nj. Dimmock, A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity, J GEN VIROL, 82, 2001, pp. 1387-1395

Authors: Edwards, MJ Dimmock, NJ
Citation: Mj. Edwards et Nj. Dimmock, Two influenza A virus-specific fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition, VIROLOGY, 278(2), 2000, pp. 423-435

Authors: Duhaut, S Dimmock, NJ
Citation: S. Duhaut et Nj. Dimmock, Approximately 150 nucleotides from the 5 ' end of an influenza A segment 1defective virion RNA are needed for genome stability during passage of defective virus in infected cells, VIROLOGY, 275(2), 2000, pp. 278-285

Authors: Cleveland, SM Buratti, E Jones, TD North, P Baralle, F McLain, L McInerney, T Durrani, Z Dimmock, NJ
Citation: Sm. Cleveland et al., Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: Its deletion leads to a strong neutralizing response, VIROLOGY, 266(1), 2000, pp. 66-78

Authors: Cleveland, SM Jones, TD Dimmock, NJ
Citation: Sm. Cleveland et al., Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1, J GEN VIROL, 81, 2000, pp. 1251-1260

Authors: McInerney, TL Brennan, FR Jones, TD Dimmock, NJ
Citation: Tl. Mcinerney et al., Analysis of the ability of five adjuvants to enhance immune responses to achimeric plant virus displaying an HIV-1 peptide, VACCINE, 17(11-12), 1999, pp. 1359-1368

Authors: Jackson, NAC Levi, M Wahren, B Dimmock, NJ
Citation: Nac. Jackson et al., Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type1 virions, J GEN VIROL, 80, 1999, pp. 225-236
Risultati: 1-11 |